Item Type | Name |
Concept
|
Central Nervous System Stimulants
|
Concept
|
Autonomic Nervous System
|
Concept
|
Autonomic Nervous System Diseases
|
Concept
|
Central Nervous System
|
Concept
|
Central Nervous System Diseases
|
Concept
|
Nervous System
|
Concept
|
Nervous System Diseases
|
Concept
|
Peripheral Nervous System Diseases
|
Concept
|
Peripheral Nervous System
|
Concept
|
Autoimmune Diseases of the Nervous System
|
Concept
|
Lupus Vasculitis, Central Nervous System
|
Academic Article
|
Intravenous immune globulin therapy for neurologic diseases.
|
Academic Article
|
Peripheral neuropathies in Sjogren syndrome: a new reappraisal.
|
Academic Article
|
Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases.
|
Academic Article
|
Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity.
|
Academic Article
|
Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia.
|
Academic Article
|
Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients.
|
Academic Article
|
Antibodies to sulfated glycolipids in Guillain-Barré syndrome.
|
Academic Article
|
Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies.
|
Academic Article
|
Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).
|
Academic Article
|
High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy.
|
Academic Article
|
Suramin-induced polyneuropathy.
|
Academic Article
|
Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy.
|
Academic Article
|
Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy.
|
Academic Article
|
Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies.
|
Academic Article
|
AIDS and the nervous system.
|
Academic Article
|
Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).
|
Academic Article
|
Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record.
|
Academic Article
|
Serologic studies of MS patients, controls, and patients with other neurologic diseases: antibodies to HTLV-I, II, III.
|
Academic Article
|
Basic principles of immunotherapy for neurologic diseases.
|
Academic Article
|
Neuromuscular diseases associated with human immunodeficiency virus infection.
|
Academic Article
|
Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease.
|
Academic Article
|
MRI findings and peripheral neuropathy in Lowe's syndrome.
|
Academic Article
|
Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathy.
|
Academic Article
|
Chronic idiopathic ataxic neuropathy.
|
Academic Article
|
Treatment of human immunodeficiency virus-related polyneuropathy with 3'-azido-2',3'-dideoxythymidine.
|
Academic Article
|
Intravenous immunoglobulin in autoimmune neuromuscular diseases.
|
Academic Article
|
The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
|
Academic Article
|
IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside.
|
Academic Article
|
Human schwann cells in tissue culture: histochemical and ultrastructural studies.
|
Academic Article
|
CSF "monoclonal" bands in chronic relapsing polyneuropathy.
|
Academic Article
|
Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy.
|
Academic Article
|
Polyneuropathy with monoclonal gammopathy: studies of 11 patients.
|
Academic Article
|
Treatment of polyneuropathy in Waldenström's macroglobulinemia: role of paraproteinemia and immunologic studies.
|
Academic Article
|
Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management.
|
Academic Article
|
Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide.
|
Academic Article
|
Amyloid in hereditary amyloid polyneuropathy is related to prealbumin.
|
Academic Article
|
The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.
|
Academic Article
|
Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin.
|
Academic Article
|
B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target.
|
Academic Article
|
Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.
|
Academic Article
|
Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins.
|
Academic Article
|
Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
|
Academic Article
|
Neuroimmunotherapy: a practical approach to the treatment of immune-mediated neurologic diseases.
|
Academic Article
|
Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge.
|
Academic Article
|
Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial.
|
Academic Article
|
High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events.
|
Academic Article
|
Advances in the pathogenesis and treatment of patients with stiff person syndrome.
|
Academic Article
|
Role of immunoglobulin light chains in the pathogenesis of amyloid polyneuropathy associated with occult plasma-cell dyscrasia.
|
Academic Article
|
Invited article: inhibition of B cell functions: implications for neurology.
|
Academic Article
|
Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens?
|
Academic Article
|
IVIg in other autoimmune neurological disorders: current status and future prospects.
|
Academic Article
|
Do anti-ganglioside antibodies cause human peripheral neuropathies?
|
Academic Article
|
B cells as therapeutic targets in autoimmune neurological disorders.
|
Academic Article
|
Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome.
|
Academic Article
|
Multiple antibodies to nerve glycoconjugates in a patient with neuropathy and monoclonal IgA gammopathy.
|
Academic Article
|
Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects.
|
Academic Article
|
Inclusion body myositis: no evidence for a neurogenic component.
|
Academic Article
|
Clinical applications of intravenous immunoglobulins in neurology.
|
Academic Article
|
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.
|
Academic Article
|
Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins.
|
Academic Article
|
Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.
|
Academic Article
|
Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
|
Academic Article
|
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy.
|
Academic Article
|
Specificity of human IgM monoclonal antibodies from patients with peripheral neuropathy.
|
Academic Article
|
Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups.
|
Academic Article
|
The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology.
|
Academic Article
|
Motor control in humans with large-fiber sensory neuropathy.
|
Academic Article
|
Exacerbation of peripheral neuropathy by lamivudine.
|
Academic Article
|
Peripheral neuropathy and antiretroviral drugs.
|
Academic Article
|
Follow-up of neuropathy from 2',3'-dideoxycytidine.
|
Academic Article
|
Peripheral neuropathy and light chain myeloma: case report.
|
Academic Article
|
Motor deficits in patients with large-fiber sensory neuropathy.
|